# Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

> **NCT00897858** · — · WITHDRAWN · sponsor: **Pediatric Brain Tumor Consortium**

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00897858
- **Lead sponsor:** Pediatric Brain Tumor Consortium
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-08
- **Primary completion:** 2014-01
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This non-therapeutic study was registered in error. The PRS team doesn't delete studies once registered, so they recommended changing the status to Withdrawn
- **Last updated:** 2013-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00897858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00897858, "Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT00897858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*